PHLARE PRECISE HLA REDIRECTING ENGAGERS
LIVE

Serial Number

98611242

Owner

Clasp Therapeutics, Inc.

Attorney

Scott M. Sisun, Esq.

Filing Date

Jun 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PHLARE PRECISE HLA REDIRECTING ENGAGERS Trademark

Serial Number: 98611242

PHLARE PRECISE HLA REDIRECTING ENGAGERS is a trademark filed by Clasp Therapeutics, Inc. on June 20, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Clasp Therapeutics, Inc. (4 trademarks)

1450 Research Boulevard, Suite 120
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

June 20, 2024

Registration Date

Not Registered

Published for Opposition

June 10, 2025

Goods & Services

pharmaceutical drug development services; scientific research; pharmaceutical research services; research and development in the pharmaceutical and biotechnology fields

pharmaceutical preparations for the prevention and treatment of cancer; chemical and biochemical preparations and substances for medical purposes for the prevention and treatment of cancer; biological preparations for the prevention and treatment of cancer

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 7, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 6, 2025 EX1G
SOU EXTENSION 1 FILED
Nov 6, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 6, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 30, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 10, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 10, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 4, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 14, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 12, 2025 REAP
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jan 14, 2025 GPRN
PRIORITY ACTION E-MAILED
Jan 14, 2025 GPRA
PRIORITY ACTION WRITTEN
Jan 14, 2025 CPRA
ASSIGNED TO EXAMINER
Jan 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2025 NWOS
NEW APPLICATION ENTERED
Jun 20, 2024 NWAP